心血管

订阅

MedSci主页 / 所有栏目 / 心血管

Radiology：血栓切除术选全麻or局麻？

2018-01-11 shaosai MedSci原创

血栓切除术麻醉手术时间
关注

本研究旨在探究是否麻醉方式（局部麻醉[GA]vs.全身麻醉[CS]）对脑卒中血管内治疗时血管造影操作的影响，并将结果发表在Radiology上。

本研究旨在探究是否麻醉方式（局部麻醉[GA]vs.全身麻醉[CS]）对脑卒中血管内治疗时血管造影操作的影响，并将结果发表在Radiology上。

SIESTA是一项单中心回顾性随机治疗性试验并比较GA与CS对血管内治疗的影响，本研究共纳入了73例行GA和CS的患者。利用SIESTA中描述性数据，分析镇定方式对脑卒中血管内治疗时血管造影操作的影响（手术时间）和及其影像学结果指标（如放射剂量）。利用T检验评价型GA和CS患者间造影关键步骤的时间。

CS和GA时从腹股沟穿刺到对颅内血管成像的时间分别为47分钟(IQR为29-70 分钟)、41分钟(IQR， 28-60分钟) (P = .546)。CS和GA时完成造影的时间分别为104分钟(IQR为75-150 分钟)、73分钟(IQR， 53-125分钟) (P = .052)。

CS和GA时透视时间分别为49分钟(IQR为25-85分钟)、35分钟(IQR， 20-74分钟) (P = .098)。在这些指标中，两种镇静方式无显着性差异。CS和GA时从穿刺到完成造影检查的时间分别为72分钟(IQR为45-109分钟)、98分钟(IQR， 64-135分钟) (P = .048)。

本研究表明，GA时由穿刺到完成造影检查的时间要短于CS。

原始出处：


本文系梅斯医学（MedSci）原创编译整理，转载需授权！

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663858, encodeId=889416638580b, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Fri Apr 13 18:58:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876980, encodeId=b4b418e698039, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 09 08:58:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314257, encodeId=a80b131425ed3, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401013, encodeId=4406140101327, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476562, encodeId=de2e14e6562f1, content=<a href='/topic/show?id=6ff229e7126' target=_blank style='color:#2F92EE;'>#全麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29771, encryptionId=6ff229e7126, topicName=全麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-04-13 12498b08m98暂无昵称

    #局麻#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1663858, encodeId=889416638580b, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Fri Apr 13 18:58:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876980, encodeId=b4b418e698039, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 09 08:58:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314257, encodeId=a80b131425ed3, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401013, encodeId=4406140101327, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476562, encodeId=de2e14e6562f1, content=<a href='/topic/show?id=6ff229e7126' target=_blank style='color:#2F92EE;'>#全麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29771, encryptionId=6ff229e7126, topicName=全麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-09-09 doctorzheng

    #切除术#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1663858, encodeId=889416638580b, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Fri Apr 13 18:58:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876980, encodeId=b4b418e698039, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 09 08:58:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314257, encodeId=a80b131425ed3, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401013, encodeId=4406140101327, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476562, encodeId=de2e14e6562f1, content=<a href='/topic/show?id=6ff229e7126' target=_blank style='color:#2F92EE;'>#全麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29771, encryptionId=6ff229e7126, topicName=全麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-13 zll0625

    #血栓切除#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1663858, encodeId=889416638580b, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Fri Apr 13 18:58:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876980, encodeId=b4b418e698039, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 09 08:58:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314257, encodeId=a80b131425ed3, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401013, encodeId=4406140101327, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476562, encodeId=de2e14e6562f1, content=<a href='/topic/show?id=6ff229e7126' target=_blank style='color:#2F92EE;'>#全麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29771, encryptionId=6ff229e7126, topicName=全麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-13 shuangle

    #血栓切除术#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1663858, encodeId=889416638580b, content=<a href='/topic/show?id=f6304e66252' target=_blank style='color:#2F92EE;'>#局麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47662, encryptionId=f6304e66252, topicName=局麻)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48cb25693766, createdName=12498b08m98暂无昵称, createdTime=Fri Apr 13 18:58:00 CST 2018, time=2018-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876980, encodeId=b4b418e698039, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 09 08:58:00 CST 2018, time=2018-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314257, encodeId=a80b131425ed3, content=<a href='/topic/show?id=585189089f4' target=_blank style='color:#2F92EE;'>#血栓切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89089, encryptionId=585189089f4, topicName=血栓切除)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=284b425, createdName=zll0625, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401013, encodeId=4406140101327, content=<a href='/topic/show?id=4a328909094' target=_blank style='color:#2F92EE;'>#血栓切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89090, encryptionId=4a328909094, topicName=血栓切除术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaZNoEMO3BP2wXbOyFTHLDM0NM4jtMZVRFjy61kQCBKjzhYeGClbvzoxiccabPRrcEaq76VWKCSNCQUqAxDnOd4w/132, createdBy=0a332291710, createdName=shuangle, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476562, encodeId=de2e14e6562f1, content=<a href='/topic/show?id=6ff229e7126' target=_blank style='color:#2F92EE;'>#全麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29771, encryptionId=6ff229e7126, topicName=全麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 13 08:58:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-13 柳叶一刀

    #全麻#

    0

相关资讯

Stroke：缺血性脑卒中，静脉溶栓联合血栓切除优于单独静脉溶栓治疗

背景：缺血性脑卒中患者的随机试验表明，与药物治疗相比（包括静脉溶栓），应用新一代的取栓装置的血管内治疗有更好的功能预后。然而，在常规临床实践中患者的死亡率及预后的普遍性尚不清楚。方法：在一项前瞻性观察性研究中，研究对象为进行静脉溶栓、取栓或联合治疗的缺血性脑卒中患者。主要预后是3个月改良Rankin量表评分（0 [无症状] -6 [死亡]分）在。采用有序逻辑回归法估计治疗效果（位移分析）的一般OR

JAMA：急性缺血性卒中行血栓切除术，选择清醒镇静还是全麻（SIESTA研究）？

由于缺乏来自随机试验的证据，对急性缺血性卒中患者血栓切除术中的最佳镇静和气道管理，仍存在争议。研究目的是，评估对于该类患者，选择清醒镇静，在患者早期神经功能改善方面，是否优于全身麻醉。SIESTA（血管内治疗脑卒中的镇静与插管研究）是一项单中心、随机、平行对照、双盲评估研究，在德国海德堡大学医院进行（2014年4月到2016年2月），包括150例急性前循环缺血性卒中患者，有较高的美国国立卫生研究院

Stroke：CTA显示的狭窄类型在血栓切除术的预测价值

本研究旨在验证由CTA显示的狭窄类型是否能够预测利用支架取组织器（SR）进行血栓切除术后血管内治疗的效果，并将结果发表在Stroke上。

Stroke：替罗非班在血管内血栓切除术中的应用

第二代支架取栓装置能够把闭塞颅内血管再通，改善急性缺血性卒中患者的预后。不过，内皮损伤不可避免，并引起动脉早期再闭塞。替罗非班是一种糖蛋白IIb/IIIa抑制剂，半衰期短，因此一些中心采用替罗非班防止局部血小板聚集，预防早期再闭塞。研究发现替罗非班用于急性中等缺血性卒中是安全的，能够降低5个月后的死亡率。对于急性缺血性卒中，采用全量阿替普酶立即桥接静脉内替罗非班也是安全和可行的。然而，一项研究

Stroke：CTA对支架血栓切除术的预测价值！

近期，一项发表在杂志Stroke上的研究评估了使用计算机断层扫描血管造影术（CTA确定的闭塞型）确定的闭塞型是否可以使用支架置入器（SR）血栓切除术预测血管内治疗的成功。此项研究回顾性分析了进行CTA检查的中风患者，然后对颅内大动脉闭塞进行血管内治疗。 CTA确定的闭塞类型分为截尾型闭塞或分支部位闭塞，并与血管内治疗期间的数字减影血管造影确定的闭塞型进行了比较。三项快速且易于评估的术前发现（CTA

​AHA2017：现场证争鸣：大面积肺栓塞治疗策略应何去何从？

大面积肺栓塞（PE）属肺栓塞中极高危。对于这些患者，即刻行血栓切除术还是体外膜肺氧合（ECMO）稳定后再择期手术？